Cern Corporation, Inc.

Company overview

Cern Corporation, Inc. / CernDevice.com. Our focus is on Women’s Health. Cern has developed the use of low level, visible spectrum, microbicidal light as a safe and effective treatment of both yeast & bacterial GYN infection, including drug resistant pathogen. Our approach focuses on three key areas. Affective Therapeutic: Cern’s approach addresses challenges to systemic drugs. We have shown safety and efficacy on both yeast and bacterial microbes including drug resistant. Anti-Microbial Resistance: Cern’s approach does not contribute to microbe resistance. Birthrate: The ability to mitigate bacterial vaginosis in a safe effective manner, without drugs, holds promise to improve conception rates as well as healthy full-term gestation.